TransCode Therapeutics, Inc. - Common Stock (RNAZ)
1.1200
+0.3500 (45.45%)
Transcode Therapeutics Inc is a biotechnology company focused on developing innovative RNA-based therapeutics aimed at treating cancer and other serious diseases
The company specializes in harnessing the potential of RNA to create targeted therapies that can address the underlying mechanisms of diseases, particularly in oncology. By leveraging its proprietary technology platforms, Transcode aims to enhance the precision of cancer treatments and improve patient outcomes, while also exploring applications in other therapeutic areas. The company's commitment to advancing RNA therapeutics positions it at the forefront of cutting-edge research in the life sciences field.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
